Hideaki Uchida

Title: Innovations by Hideaki Uchida in Lactobacilli Screening

Introduction

Hideaki Uchida is a notable inventor based in Miyagi, Japan. He has made significant contributions to the field of biotechnology, particularly in the screening of human ABO blood group-binding lactobacilli. With a total of 2 patents, Uchida's work has implications for yogurt production and health.

Latest Patents

Uchida's latest patent focuses on a method for screening human ABO blood group-binding lactobacilli. The screening methods utilize surface plasmon resonance spectrums along with human intestinal mucin and blood group antigens as probes. A trial was conducted to establish selection criteria for these screening methods, aiming to adapt them for mass screening. It was discovered that lactobacilli compatible with ABO blood groups could be identified by setting 100 RU as a criterion for judging bacterial binding under specific conditions. Using 238 strains, the screening methods and tests were carried out to determine their compatibility for yogurt production, ultimately identifying strains compatible with blood groups A, B, and O.

Career Highlights

Throughout his career, Uchida has worked with prominent companies such as Meiji Co., Ltd. and Meiji Dairies Corporation. His innovative approaches have contributed to advancements in the dairy industry, particularly in the development of probiotic products.

Collaborations

Uchida has collaborated with notable coworkers, including Tadao Saito and Yasushi Kawai. Their combined expertise has furthered research and development in the field of lactobacilli screening.

Conclusion

Hideaki Uchida's contributions to the field of biotechnology, particularly in the screening of lactobacilli, demonstrate his innovative spirit and dedication to improving health through food science. His work continues to influence the dairy industry and probiotic research.